{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Laura Herring"}, {"accession": "MS:1000589", "name": "contact email", "value": "laura_herring@med.unc.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "UNC-Chapel Hill"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Nathaniel J. Moorman"}, {"accession": "MS:1000589", "name": "contact email", "value": "nathaniel_moorman@med.unc.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Department of Microbiology & Immunology UNC School of Medicine UNC-Chapel Hill"}]}], "datasetFiles": [{"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276/20160425_PC101-Moorman-MIBS_S1-Mock.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276/20160425_PC101-Moorman-MIBS_S2-A24.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276/20160425_PC101-Moorman-MIBS_S3-A48.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276/20160425_PC101-Moorman-MIBS_S4-A72.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276/20160425_PC101-Moorman-MIBS_S5-T24.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276/20160425_PC101-Moorman-MIBS_S6-T48.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276/20160425_PC101-Moorman-MIBS_S7-T72.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276/20160706_PC130-Moorman-MIBS_S1-Mock.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276/20160706_PC130-Moorman-MIBS_S2-A24.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276/20160706_PC130-Moorman-MIBS_S3-A48.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276/20160706_PC130-Moorman-MIBS_S4-A72.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276/20160706_PC130-Moorman-MIBS_S5-T24.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276/20160706_PC130-Moorman-MIBS_S6-T48.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276/20160706_PC130-Moorman-MIBS_S7-T72.raw"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276/MaxQuant Results.zip"}], "description": "240 cellular kinases simultaneously in cells infected with a laboratory-adapted (AD169) or clinical (TB40E) HCMV strain using a label-free approach. Significant time-dependent changes for multiple kinases including cell cycle, receptor tyrosine and mitotic kinases were observed. Based on these data, we tested antiviral activity of 14 kinase inhibitors, and the most potent inhibitor blocked HCMV early gene expression and viral DNA accumulation. These results show the utility of kinome profiling to screen kinase inhibitors that can be repurposed as antivirals.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD005276"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD005276"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD005276"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "kinome, human herpesvirus, HCMV, virology, antivirals, kinase inhibitors, label-free quantitation"}], "modifications": [{"accession": "MOD:00696", "name": "phosphorylated residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "28237943"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Arend KC, Lenarcic EM, Vincent HA, Rashid N, Lazear E, McDonald IM, Gilbert TS, East MP, Herring LE, Johnson GL, Graves L, Moorman NJ. Kinome Profiling Identifies Druggable Targets For Novel HCMV Antivirals. Mol Cell Proteomics. 2017 Feb 25. pii: mcp.M116.065375"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Kinome profiling upon HCMV infection using the MIB-MS approach"}